Stem Cell-Based Therapies for Ischemic Stroke | Zendy

Lei Hao | Zendy; Zhongmin Zou | Zendy; Hong Tian | Zendy; Yubo Zhang | Zendy; Huchuan Zhou | Zendy; Lei Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stem Cell-Based Therapies for Ischemic Stroke

Author(s) -

Lei Hao,

Zhongmin Zou,

Hong Tian,

Yubo Zhang,

Huchuan Zhou,

Lei Liu

Publication year - 2014

Publication title -

biomed research international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.772

H-Index - 126

eISSN - 2314-6141

pISSN - 2314-6133

DOI - 10.1155/2014/468748

Subject(s) - stem cell , induced pluripotent stem cell , mesenchymal stem cell , embryonic stem cell , neural stem cell , neurogenesis , stem cell therapy , homing (biology) , medicine , cell therapy , transplantation , cancer research , neuroscience , biology , microbiology and biotechnology , pathology , ecology , biochemistry , gene

In recent years, stem cell-based approaches have attracted more attention from scientists and clinicians due to their possible therapeutical effect on stroke. Animal studies have demonstrated that the beneficial effects of stem cells including embryonic stem cells (ESCs), inducible pluripotent stem cells (iPSCs), neural stem cells (NSCs), and mesenchymal stem cell (MSCs) might be due to cell replacement, neuroprotection, endogenous neurogenesis, angiogenesis, and modulation on inflammation and immune response. Although several clinical studies have shown the high efficiency and safety of stem cell in stroke management, mainly MSCs, some issues regarding to cell homing, survival, tracking, safety, and optimal cell transplantation protocol, such as cell dose and time window, should be addressed. Undoubtably, stem cell-based gene therapy represents a novel potential therapeutic strategy for stroke in future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research